Unknown

Dataset Information

Urine and serum midkine levels in an Australian chronic kidney disease clinic population: an observational study.


ABSTRACT:

Background and objectives

The cytokine midkine (MK) is pathologically implicated in progressive chronic kidney disease (CKD) and its systemic consequences and has potential as both a biomarker and therapeutic target. To date, there are no published data on MK levels in patients with different stages of CKD. This study aims to quantify MK levels in patients with CKD and to identify any correlation with CKD stage, cause, progression, comorbid disease or prescribed medication.

Methods

In this observational, single-centre study, demographic data were collected, and serum and urine assayed from 197 patients with CKD and 19 healthy volunteers in an outpatient setting.

Results

The median serum and urine MK level in volunteers was 754 pg/mL (IQR: 554-1025) and 239 pg/mL (IQR:

SUBMITTER: Campbell VK 

PROVIDER: S-EPMC5623449 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature